The lead
July 7, 2026 - Pittsburgh - Ryan O'Hearn earned 26 hitting FP, Paul Skenes added 13 pitching FP, and the Pittsburgh Pirates routed the Atlanta Braves 12-4 at PNC Park, per the Associated Press recap on CBS Sports.
How the game turned
Pittsburgh jumped on Atlanta early and kept adding runs through the middle innings. The Braves scored four times but never threatened a comeback against a Pirates lineup that piled up crooked numbers at home.
Pitching and matchup notes
Skenes' 13 pitching FP start set the tone while the bullpen held the Braves to four runs. AthX Engine graded Pittsburgh pitching as the stabilizer behind the offensive burst.
Bats that changed the board
O'Hearn's 26 hitting FP paced the offense—the daily hitting lead on the Tuesday card. AthX Engine graded the Pirates at 23 team FP, second only to Milwaukee's doubleheader sweep.
AthX Engine fantasy angle
AthX Engine rewards blowout nights when a slugger and ace stack on the same card. O'Hearn's 26 FP and Skenes' 13 FP register on separate daily leaderboards from dynamic pricing.
What comes next
The Braves and Pirates played again Wednesday in Pittsburgh.
*Sources: MLB.com schedule, CBS Sports/AP recap, AthX Engine scoring. Information only; not financial advice.*
Ready to trade Pirates 12, Braves 4: O'Hearn Twenty-Six Hit FP, Skenes Thirteen Pitch FP?
Download the AthX Android app, or sign up on the web. Trade player and team shares with low 1–4% fees and performance-linked pricing.
Launch bonus ends April 30 · 2026 MLB launch window
Earn up to $500 in bonus player shares as an eligible new account — fund with qualifying monthly deposits (terms apply).
Web signup: https://getathx.com/signup
Double up: referrals + launch promo
Refer a friend before April 30 — when they fund with $100+, you can both earn bonus shares through the referral program, in addition to the limited-time up to $500 in bonus player shares launch offer (terms apply).
Explore AthX trading pages
Browse searchable directories or jump to featured player and team pages (stats, projections, FAQs).